Additional file 1: of Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial Jona Walk Isaie Reuling Marije Behet Lisette Meerstein-Kessel Wouter Graumans Geert-Jan van Gemert Rianne Siebelink-Stoter Marga van de Vegte-Bolmer Thorsten Janssen Karina Teelen Johannes de Wilt Quirijn de Mast AndrĂŠ van der Ven Ernest Diez Benavente Susana Campino Taane Clark Martijn Huynen Cornelus Hermsen Else Bijker Anja Scholzen Robert Sauerwein 10.6084/m9.figshare.c.3879430_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Modest_heterologous_protection_after_Plasmodium_falciparum_sporozoite_immunization_a_double-blind_randomized_controlled_clinical_trial/5405755 Protocol. Malaria antigen-specific IgG ELISA (S1). Isolation and cultivation of primary human hepatocytes (S2). In vitro sporozoite infectivity assay of primary human hepatocytes (S3). Immunofluorescent analysis of P. falciparum-infected primary human hepatocytes (S4). In vitro PBMC restimulation with PfRBCs and flow cytometry staining (S5) [11, 12, 14, 17, 42]. (DOCX 20 kb) 2017-09-13 05:00:00 Plasmodium falciparum Malaria Vaccine Sporozoite Controlled human malaria infection Heterologous protection Immune responses